Patent: 11,273,205
✉ Email this page to a colleague
Summary for Patent: 11,273,205
| Title: | IL-15 protein complex pharmaceutical composition |
| Abstract: | The present disclosure relates to a pharmaceutical composition, which comprises an IL-15 protein complex and a citrate buffer solution. In addition, the pharmaceutical composition may also comprise a sugar and a non-ionic surfactant. The pharmaceutical composition in the present disclosure demonstrates a high degree of stability even after being stored at 2-8° C. for several months. |
| Inventor(s): | Tingting Wu, Hao Li, Xun Liu |
| Assignee: | Jiangsu Hengrui Medicine Co Ltd , Shanghai Hengrui Pharmaceutical Co Ltd |
| Application Number: | US16/632,411 |
| Patent Claims: | see list of patent claims |
Details for Patent 11,273,205
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Octapharma Pharmazeutika Produktionsges.m.b.h. | WILATE | von willebrand factor/coagulation factor viii complex (human) | For Injection | 125251 | December 20, 2010 | ⤷ Start Trial | 2038-07-24 |
| Janssen Biotech, Inc. | STELARA | ustekinumab | Injection | 761044 | September 23, 2016 | ⤷ Start Trial | 2038-07-24 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 11,273,205
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 201908610 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2019019998 | ⤷ Start Trial |
| United States of America | 2020230210 | ⤷ Start Trial |
| Ukraine | 125971 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
